2Rockwood K,Howard K,MacKnight C,et al.Spectrum of disease in vascular cognitive impairmem[J].Neuroepidemiology,1999,18:248-254.
3Wentzel C,Darvesh S,Macknight C,et al.Inter-rater reliability of the diagnosis of vascular cognitive impairment at a memory clinic[J].Neuroepidemiology,2000,19:186-193.
4Kuller LH,Lopez OL,Jagnst WJ,et al.Determinants of vascular dementia in the cardiovascular health cognition study[J].Neurology,2005,64:1548-1552.
5Garrett KD,Browndyke JN,Whelihan W,et al.The neuropsych-ological profile of vascular cognitive impairment-no dementia:comparisons to patients at risk for cerebrovascular disease and vascular dementia[J].Arch Clin Neuropsychol,2004,19:745.
10Yoshita M,Fletcher E,Harvey D,et al.Extent and distribution of white matter hyperintensities in normal aging,MCI,and AD[J].Neurology,2006,67:2192-2198.
4Aharon-Peretz J,Daskovski E,Mashiach T, et al.Progression of dementia associated with lacunar infarctions. Dement Geriatr Cogn Disord 2003;16(2):71-7
5Lopez-Arrieta JM,Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev 2002;(3):CD000147
6Laukka EJ,Jones S,Fratiglioni L,et al.Cognitive functioning in preclinical vascular dementia: a 6-year follow-up. Stroke 2004;35(8):1805-9
7Garrett KD,Paul RH,Libon DJ,et al.Defining the diagnosis of vascular dementia.Appl Neuropsychol 2004; 11(4):202-7
8Wallin A,Sjogren M,Edman A,et al.Symptoms,vascular risk factors and bloodbrain barrier function in relation to CT white-matter changes in dementia. Eur Neurol 2000;44(4):229-35
9Kruglov LS.The early stage of vascular dementia: significance of a complete therapeutic proaam.Int J Geriatr Psychiatry 2003;18(5):402-6
10Wallin A. Current definition and classification of dementia diseases. Acta Neurol Scand Suppl 1996; 168:39 - 44.
共引文献45
1Yicheng Liu1, Hongxing Zhang2, Wei Huang3, Wenjun Wan3, Hongfen Peng1 1Department of Radiology, 2Department of Acupuncture and Moxibustion, Wuhan Hospital of Integrated Chinese and Western Medicine, Wuhan 430022, Hubei Province, China,3Department of Acupuncture and Osteology, Hubei College of Traditional Chinese Medicine, Wuhan 430061, Hubei Province, China.MRI evaluation of vascular dementia[J].Neural Regeneration Research,2006,1(8):741-743.
4Hachinski V, Ladecola C, Petersen RC, et al. National Institute of Neurological. Disorders and Stroke-Canadian Stroke Network vascular cognitiveimpairment harmoniza- tion standards. Stroke, 2006, 37: 2220-2241.
5Martfnez-Vila E , Murie-Fem6ndez M, G611ego P6rez- Larraya J, et al. Neuroprotection in Vascular Dementia. Cerebrovasc Dis, 2006, 21: S106-Sl17.
6Winblad B, Fioravanti M, Dolezal T, et al. Therapeutic use of nicergoline. Clin Drug Investig, 2008, 28 : 533- 535.
7Baskys A, Hou AC. Vascular demetia: pharmacological treatment approaches and perspectives. Clin Interv Ag- ing, 2007, 2: 327-335.
8Hachinski Vladimir,Iadecola Costantino,Petersen Ron C,Breteler Monique M,Nyenhuis David L,Black Sandra E,Powers William J,DeCarli Charles,Merino Jose G,Kalaria Raj N,Vinters Harry V,Holtzman David M,Rosenberg Gary A,Wallin Anders,Dichgans Ma.National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke; a journal of cerebral circulation . 2006
